Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 23269079)

1.
2.

Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report.

Kuroda T, Sato H, Nakatsue T, Wada Y, Murakami S, Nakano M, Narita I.

BMC Res Notes. 2014 Apr 11;7:229. doi: 10.1186/1756-0500-7-229.

3.

Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.

Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, Kimura Y, Takeuchi M, Yoshida M, Ishibashi Y, Nakashima S, Sugita Y, Miura O, Ohshima K.

Eur J Haematol. 2013 Jul;91(1):20-8. doi: 10.1111/ejh.12116. Epub 2013 May 13. Erratum in: Eur J Haematol. 2013 Dec;91(6):565.

PMID:
23560463
4.

Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.

Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, Nakatsuka S, Tamaru J, Iizuka A, Takeuchi T, Aozasa K.

J Rheumatol. 2007 Feb;34(2):322-31. Epub 2006 Nov 15.

PMID:
17117491
5.

Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate.

Sibilia J, Lioté F, Mariette X.

Rev Rhum Engl Ed. 1998 Apr;65(4):267-73. Review.

PMID:
9599795
6.

Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.

Kondo S, Tanimoto K, Yamada K, Yoshimoto G, Suematsu E, Fujisaki T, Oshiro Y, Tamura K, Takeshita M, Okamura S.

Virchows Arch. 2013 Apr;462(4):399-407. doi: 10.1007/s00428-013-1389-1. Epub 2013 Mar 14.

PMID:
23494713
7.

[Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis].

Pastor-Nieto MA, Kilmurray LG, López-Chumillas A, O'Valle F, García-Del Moral R, Puig AM, Bautista P.

Actas Dermosifiliogr. 2009 Mar;100(2):142-6. Review. Spanish.

PMID:
19445880
8.

[2-year complete remission after withdrawal of methotrexate in a rectal methotrexate-associated diffuse large B-cell lymphoma].

Ogasawara T, Kimura A, Yasuyama M, Ohtuka K, Aiba M, Kawauchi K.

Rinsho Ketsueki. 2007 Jun;48(6):485-90. Japanese.

PMID:
17633096
9.

Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.

Miyazaki T, Fujimaki K, Shirasugi Y, Yoshiba F, Ohsaka M, Miyazaki K, Yamazaki E, Sakai R, Tamaru J, Kishi K, Kanamori H, Higashihara M, Hotta T, Ishigatsubo Y.

Am J Hematol. 2007 Dec;82(12):1106-9.

PMID:
17654684
10.

Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.

Ishida M, Hodohara K, Yoshii M, Okuno H, Horinouchi A, Nakanishi R, Harada A, Iwai M, Yoshida K, Kagotani A, Yoshida T, Okabe H.

Int J Clin Exp Pathol. 2013 Sep 15;6(10):2237-41. eCollection 2013.

11.

Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate.

Niitsu N, Okamoto M, Nakamine H, Hirano M.

Cancer Sci. 2010 May;101(5):1309-13. doi: 10.1111/j.1349-7006.2010.01517.x. Epub 2010 Jan 28.

PMID:
20210795
12.
13.

Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.

Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, Schultz M, Murren J.

J Clin Oncol. 1996 Jun;14(6):1943-9. Review.

PMID:
8656264
14.

Epstein-Barr virus and methotrexate-related CNS lymphoma in a patient with rheumatoid arthritis.

Migita K, Miyashita T, Mijin T, Sakito S, Kurohama H, Ito M, Toda K, Tsustumi K, Baba H, Izumi Y, Kawakami A, Niino D, Ohshima K.

Mod Rheumatol. 2013 Jul;23(4):832-6. doi: 10.1007/s10165-012-0717-7. Epub 2012 Jul 24.

PMID:
22825547
15.

Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.

Quartuccio L, De Re V, Fabris M, Marzotto A, Franzolini N, Gasparotto D, Caggiari L, Ferraccioli G, Scott CA, De Vita S.

Haematologica. 2006 May;91(5):691-4.

16.

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.

Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, Hessey E, Chen A, Tyrrell H, Shaw TM; IMAGE Investigators.

Ann Rheum Dis. 2011 Jan;70(1):39-46. doi: 10.1136/ard.2010.137703. Epub 2010 Oct 11.

PMID:
20937671
17.

B-cell therapies in established rheumatoid arthritis.

Leandro MJ, Becerra-Fernandez E.

Best Pract Res Clin Rheumatol. 2011 Aug;25(4):535-48. doi: 10.1016/j.berh.2011.10.005. Review.

PMID:
22137923
18.
19.

Epstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease : a case report and review of the literature.

Sekiguchi Y, Shimada A, Imai H, Wakabayashi M, Sugimoto K, Nakamura N, Sawada T, Komatsu N, Noguchi M.

J Clin Exp Hematop. 2012;52(3):211-8. Review.

20.

Epstein-Barr virus infection associated hepatic lymphoma in a patient treated with methotrexate for rheumatoid arthritis.

Soubrier M, Arrestier S, Bouloudian S, Dubost JJ, Ristori JM.

Joint Bone Spine. 2006 Mar;73(2):218-9. Epub 2006 Jan 30. No abstract available.

PMID:
16495108
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk